Annovis And Buntanetap: Asymmetric Risk/Reward Ahead Of Parkinson’s Data Readout (ANVS)

nerve cells,concept for Neurologic Diseases, tumors and brain surgery.

Ralwel

Update as of 12:00PM ET, 3/30/23: Annovis Phase 3 interim data presentation rescheduled to Saturday (1/1/23) due to scheduling issues at the AD/PD 2023 conference, according to sources. Not yet confirmed.

Intro

With an interim readout of Phase 3 Parkinson’s


Read more here: Source link